Skip to content
lifestyle.brickvest.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
DAEWOONG PHARMACEUTICAL
CGBIO Receives FDA 510(k) Clearance for Patient-Specific Titanium Implant ‘EASYMADE TI’
May 23, 2026
Daewoong Pharmaceutical Hosts ‘NABOTA Master Class’… Highlighting Safety Amid Growing Demand for High-Dose, Repetitive Treatments
May 23, 2026
CGBIO Showcases Comprehensive Medical Device Portfolio at KIMES 2026 Achieves KRW 5.3 Billion in Contract Results
May 20, 2026
CGBIO Showcases Minimally Invasive Spine Surgery Techniques in Thailand: “Smaller Incisions, Faster Recovery”
May 19, 2026
Daewoong Pharmaceutical: Third IDMC Reaffirms Safety of Bersiporocin and Recommends Continuation of Global Phase 2 Clinical Trial
October 27, 2025